Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Pasithea Therapeutics Corp (KTTA)

Pasithea Therapeutics Corp (KTTA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 23,288
  • Shares Outstanding, K 23,288
  • Annual Sales, $ 20 K
  • Annual Income, $ -2,170 K
  • 60-Month Beta N/A
  • Price/Sales 1,561.60
  • Price/Cash Flow N/A
  • Price/Book 0.46
Trade KTTA with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9100 +9.89%
on 06/23/22
1.1800 -15.25%
on 06/09/22
+0.0300 (+3.09%)
since 06/01/22
3-Month
0.8113 +23.26%
on 05/26/22
1.3500 -25.93%
on 04/14/22
-0.2900 (-22.48%)
since 04/01/22

Most Recent Stories

More News
Investor Group Comments on Pasithea Therapeutics’ Seemingly Defensive and Dilutive Related-Party Acquisition of Alpha-5

Camac Partners, LLC, affiliates of Concord Investment Partners Ltd., and Leonite Capital LLC (collectively with their affiliates, the "Investor Group" or "we"), who together are the largest stockholder...

KTTA : 1.0000 (-0.99%)
Pasithea Therapeutics to Participate in the H.C. Wainwright 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics and Beyond

MIAMI BEACH, Fla., June 23, 2022 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a novel biotechnology...

KTTAW : 0.0661 (+2.01%)
KTTA : 1.0000 (-0.99%)
Revenues From Treatment of Rare Neurological Disorders Worldwide Are Poised to Surpass $12 Billion in 2026

Palm Beach, FL – June 22, 2022 – FinancialNewsMedia.com News Commentary Neuroinflammatory disorder is the study of conditions where immune responses which damage components of the nervous system. It...

KTTA : 1.0000 (-0.99%)
IONS : 38.06 (+2.81%)
DNLI : 31.24 (+6.15%)
AMLX : 19.47 (+1.09%)
CYTK : 41.00 (+4.35%)
Revenues From Treatment of Rare Neurological Disorders Worldwide Are Poised to Surpass $12 Billion in 2026

/PRNewswire/ -- Neuroinflammatory disorder is the study of conditions where immune responses which damage components of the nervous system. It includes many...

KTTA : 1.0000 (-0.99%)
IONS : 38.06 (+2.81%)
DNLI : 31.24 (+6.15%)
AMLX : 19.47 (+1.09%)
CYTK : 41.00 (+4.35%)
Pasithea Therapeutics Acquires Alpha-5 Integrin, LLC

- Alpha-5 is a potentially first-in-class monoclonal antibody for the treatment of amyotrophic lateral sclerosis (ALS) and other neurological diseases --...

KTTA : 1.0000 (-0.99%)
KTTAW : 0.0661 (+2.01%)
Pasithea Therapeutics to Present at the NobleCon18 Investor Conference 2022

MIAMI BEACH, Fla., April 14, 2022 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a novel biotechnology...

KTTAW : 0.0661 (+2.01%)
KTTA : 1.0000 (-0.99%)
Pasithea Therapeutics Announces Financial and Business Results for the Fourth Quarter and Full Year 2021 and Business Update for 2022

-- Cash Balance of $52.9 million to fund operations well into 2024 ---- Initiation of a drug development program in schizophrenia ---- Initiation of a drug...

KTTA : 1.0000 (-0.99%)
KTTAW : 0.0661 (+2.01%)
Rising Number of Mental Health Disorders Fuel Advancing Initiatives to Reduce Psychiatric and Neurological Conditions

Palm Beach, FL –– March 8, 2022 – FinancialNewsMedia.com News Commentary – According to a report from Grand View Research “High unmet medical needs and government initiatives to reduce the psychiatric...

KTTA : 1.0000 (-0.99%)
ALKS : 30.53 (+2.48%)
PASG : 2.38 (+0.85%)
ACHC : 71.58 (+5.84%)
ATAI : 3.65 (+0.27%)
Psychedelic Drugs Market Growing as Prevalence of Mental Health Issues are Increasing Globally

Palm Beach, FL –– February 24, 2022  – FinancialNewsMedia.com News Commentary – The prevalence of mental health disorders has risen exponentially but the development of novel medications has not...

KTTA : 1.0000 (-0.99%)
ATRA : 8.30 (+6.55%)
BIIB : 210.63 (+3.28%)
TEVA : 7.89 (+4.92%)
RLMD : 18.30 (-3.63%)
Pasithea Therapeutics Strengthens its Scientific Advisory Board with the Appointment of Preeminent Scientist Dr. Daniel Weinberger

Newest member is a renowned thought leader in the identification of neurobiological mechanisms of mental illness...

KTTAW : 0.0661 (+2.01%)
KTTA : 1.0000 (-0.99%)

Business Summary

Pasithea Therapeutics Corp. is a biotechnology company. It focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. Pasithea Therapeutics Corp. is based in MIAMI BEACH, Fla.

See More

Key Turning Points

3rd Resistance Point 1.0364
2nd Resistance Point 1.0232
1st Resistance Point 1.0116
Last Price 1.0000
1st Support Level 0.9868
2nd Support Level 0.9736
3rd Support Level 0.9620

See More

52-Week High 8.5000
Fibonacci 61.8% 5.5629
Fibonacci 50% 4.6557
Fibonacci 38.2% 3.7484
Last Price 1.0000
52-Week Low 0.8113

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar